Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.
about
Dried blood spot collection of health biomarkers to maximize participation in population studiesQuantifying cardiometabolic risk using modifiable non-self-reported risk factorsPredictive accuracy of the Framingham coronary risk score in British men: prospective cohort studyThe 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of riskThe 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of riskThe 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of riskCan non-physician health-care workers assess and manage cardiovascular risk in primary care?The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of riskA computer decision aid for medical prevention: a pilot qualitative study of the Personalized Estimate of Risks (EsPeR) systemCombining information from multiple data sources to create multivariable risk models: illustration and preliminary assessment of a new methodEvidence-based prescribing of statins: a developing world perspective.Reassessing the Usefulness of Coronary Artery Calcium Score among Varying Racial and Ethnic Groups by Geographic Locations: Relevance of the Korea Initiatives on Coronary Artery Calcification RegistryClassical and novel biomarkers for cardiovascular risk prediction in the United StatesIs there a consistent association between coronary heart disease and ischemic stroke caused by intracranial atherosclerosis?Prognostic indices for older adults: a systematic reviewDisease risk score as a confounder summary method: systematic review and recommendationsSystematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone densityUtility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKDCardiovascular risks associated with low dose ionizing particle radiationHIV infection and the risk of acute myocardial infarction.Role of clopidogrel in unstable angina and non-ST-segment elevation myocardial infarction: from literature and guidelines to practiceRelationships among stress measures, risk factors, and inflammatory biomarkers in law enforcement officersRaltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infectionUsing genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degenerationUsing additional information on working hours to predict coronary heart disease: a cohort studyDistribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results)Calibration of Proportional Hazards and Accelerated Failure Time ModelsHypertension-Related Morbidity and Mortality in African Americans?Why We Need to Do BetterUsing Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study.Association Between Earlobe Crease and the Metabolic Syndrome in a Cross-sectional Study.Development of a cardiovascular risk score for use in low- and middle-income countriesPredicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran.Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation.Big data in organ transplantation: registries and administrative claims.Description of the Framingham Heart Study data for Genetic Analysis Workshop 13.Far from easy and accurate - detection of metabolic syndrome by general practitioners.A Naive Bayes machine learning approach to risk prediction using censored, time-to-event data.Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of
P2860
Q23918411-52FF0A69-D307-4035-BF90-9EA80D42FA16Q24169777-3B39B0A3-555D-42CF-BE8F-9AAD59E0F199Q24630111-71FDA720-92C7-4510-9251-4165415B5466Q24645401-0518252F-9011-4D05-9076-9C4C293C68F2Q24651499-870BFA5E-DA82-4AF6-BAE6-E7E12275A813Q24652860-0BEF0551-283F-47FC-97B7-4C3676046093Q24657952-4CA54893-C2D0-49BD-B71B-4E2C567BA41DQ24658014-04AB695C-9E62-4D98-BBE6-07BDBBF8CA4BQ24806011-5BEDFA0E-D3F2-4921-8325-E0735DD17692Q24811660-9A7BDA62-58F3-49C4-B32D-E1D9A644DE4CQ25255887-A14A61DC-130A-4BB4-B561-4684B6CE975EQ26772283-391AD1CF-3388-4231-9095-570E03E88C92Q26824026-FC12C8A2-84B1-4823-B3FA-F38324BE2079Q26851408-590A7048-ED11-438D-B1C4-286EEF667B6DQ26865698-124AE00A-1145-4941-90F4-629F44E24A89Q26999267-BFC91135-AFC7-4DF9-9FC7-DB0BCBFAD11CQ27026680-70B5CFDF-DFE6-4631-A37E-E9AF5405870EQ27027063-FF9BA74B-760D-4E9F-9349-080792C25CC1Q27335261-15E65967-416F-4500-8C90-5017AD30D2D5Q27347231-06623FFF-444D-4C84-A52F-2C041B354F41Q28211998-F6A63B10-3569-4BDD-BCFA-A1B672AFE7EAQ28392174-A3397B89-2B7D-4AAB-A63E-9768E5FCB53AQ28543732-6C45A1E4-25D8-401A-A1E5-8EEE0CD27351Q28741677-E0AF3F64-5269-4D3D-9034-71B3B6E5D1D8Q28741690-37D83A12-A521-42CA-A94D-F512D71048B2Q28744014-459371FC-ED58-4057-80CA-6A3EC8980AFFQ29026803-8C33C7BD-81FC-4366-ACB3-905E93D80F0AQ29399489-6668D103-CC1F-4FA7-9775-DA7EF5C716D9Q30234498-38620E75-ADF3-49E8-BCF4-E9CB5AE3075DQ30438730-00999B98-65A1-49E9-A2DA-DBB3C75970BEQ30463590-2AF54B03-B512-48F3-9F23-D30CC48440EBQ30501026-F2E4B826-219E-40FA-B0A6-9706A3B116CCQ30573969-2DE4B4B3-4AB7-4B90-8A1D-8229DB5159BCQ30582591-66C7C660-9ECD-4344-BA63-6341A95843F9Q30681951-AAF5770A-32B3-4B1C-865F-5A083FCCF330Q30837288-E85441EA-E4BB-470C-93FE-5047B8833AF6Q30907271-5BEC5314-5834-4623-A64B-978A2EAB2D02Q30931643-872A2308-7B8F-418D-A84A-32B31D22B324Q30952713-9E383B4C-A9C2-45E8-9EAC-06447374DD26Q30987054-65D36652-6A2F-451D-9504-A5617F2C4067
P2860
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Validation of the Framingham c ...... e ethnic groups investigation.
@en
Validation of the Framingham c ...... e ethnic groups investigation.
@nl
type
label
Validation of the Framingham c ...... e ethnic groups investigation.
@en
Validation of the Framingham c ...... e ethnic groups investigation.
@nl
prefLabel
Validation of the Framingham c ...... e ethnic groups investigation.
@en
Validation of the Framingham c ...... e ethnic groups investigation.
@nl
P2093
P356
P1476
Validation of the Framingham c ...... e ethnic groups investigation.
@en
P2093
CHD Risk Prediction Group
R B D'Agostino
P304
P356
10.1001/JAMA.286.2.180
P407
P577
2001-07-01T00:00:00Z